GlassScriptPhysician profile
Steven L Jensen
NPI 1154314193
$5,593.91
in general payments reported to CMS, 2019-2025
33 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,267 · 2020: $249 · 2021: $317 · 2022: $40.45 · 2023: $807 · 2024: $596 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,620 · Education: $77.97 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,619.53 |
| Education | $77.97 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,108.84 | 2019-2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $810.62 | 2019-2023 | Spaceoar Vue System - 10ml |
| Teleflex LLC | $719.25 | 2021-2025 | Urolift, Barrigel |
| Medtronic, INC. | $241.94 | 2021-2025 | Interstim |
| Pfizer INC. | $179.56 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $177.40 | 2024-2025 | Keytruda, Keytruda Qlex |
| Medtronic USA, INC. | $156.93 | 2019-2020 | |
| Astellas Pharma US INC | $136.23 | 2024-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $133.95 | 2024-2025 | Orgovyx, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $111.01 | 2024-2025 | Lynparza |
| Coloplast Corp | $99.91 | 2024-2025 | |
| Olympus America INC. | $74.89 | 2024-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $73.05 | 2025 | Adstiladrin |
| Janssen Biotech, INC. | $64.22 | 2024-2025 | Erleada, Akeega |
| Urogen Pharma, INC. | $61.97 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $52.35 | 2025 | |
| Tolmar, INC. | $51.53 | 2025 | Eligard, Jatenzo |
| Endo USA, INC. | $31.61 | 2024-2025 | Xiaflex |
| Avyxa Pharma, LLC | $28.38 | 2025 | |
| Amgen INC. | $26.40 | 2024 | Prolia |
| Smith+Nephew, INC. | $24.73 | 2025 | Grafix Pl |
| Immunitybio, INC. | $24.31 | 2025 | |
| Abbvie INC. | $23.20 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $21.82 | 2025 | Purewick Female External Catheter |
| Myriad Genetic Laboratories, INC. | $21.06 | 2024 | Prolaris |
| Valencia Technologies Corporation | $19.90 | 2025 | Ecoin Device Kit |
| Cycle Pharmaceuticals INC | $19.39 | 2025 | Venxxiva |
| Novartis Pharmaceuticals Corporation | $19.12 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.70 | 2024 | |
| Calyxo, INC. | $16.49 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $16.13 | 2021 | |
| Rochester Medical Corporation | $15.25 | 2021 | |
| Neotract INC. | $13.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.